Results of PPMD-Funded Study Prompt Phase III Study of Tadalafil in Duchenne

Based on the results of a recent PPMD-funded study, Eli Lilly has begun a Phase III study to determine if tadalafil, a drug typically prescribed for erectile dysfunction or increased pressure in the arteries, can slow the progression of Duchenne.
Source: Parent Project Muscular Dystrophy - Category: Neurology Source Type: news